7285 InSync III Protect
Cardiac Resynchronization Therapy - Defibrillation (CRT-Defib)
7285 InSync III Protect
Information

Device Survival Probability

7285_7295_SURV
Loading...










    at 0.0 mo                  
  • Including Normal Battery Depletion – This curve includes devices that have reached at least 80% of expected longevity. This curve is most representative of clinical performance and how long the device will last.
  • Excluding Normal Battery Depletion – This is the malfunction free survival curve.
Information

Advisories For This Model

  • There are no advisories for this model.

Performance Notes For This Model

    • There are no performance notes for this model.
Information

Product Characteristics

Generator Type CRT-Defib
NBD Code VVE-DDDR
Max. Delivered Energy 30 J
More
Connector Style CRT-D Style
Serial Number Prefix PPC
Mass 77 g
Volume 38 cc
Waveform Biphasic
X-Ray ID PPC
Hide this content
CRT-D Style
Information

Estimated Longevity

Charging Frequency 100% Pacing 50% Pacing 15% Pacing 100% Sensing
Monthly 3.3 3.7 4.0 4.2
Quarterly 4.2 4.9 5.5 5.9
Semi-annual 4.5 5.4 6.2 6.6
Footnote

Longevity estimates based on the following device usage. Pacing Mode DDD; Atrial Lower Pacing Rate 60ppm; Ventricular Lower Pacing Rate 60ppm; Atrial Pulse Width 0.4ms; Ventricular Pulse Width 0.4ms; Atrial Pulse Amplitude 3V; Ventricular Pulse Amplitude 3V; Atrial Impedance 510ohms; Ventricle Impedance 510ohms; Atrial Sensing Rate 70bpm; Ventricle Sensing Rate 70bpm; EGM prestorage OFF; Intergrated bi-ventricular pacing RV+LV; Left Ventricle Impedance 510ohms; Left Ventricular Pulse Width 0.4ms; Left Ventricular Pulse Amplitude 3V; Optivol ON; Atrial Fib percentage of time 0%; Charging frequency assumes maximum energy charge and includes therapy shocks and capacitor formation. Hide this content

Information

EOL Indication

The minimum time between ERI and EOL is 3 months (100% pacing, two charges per month).

Information

Distribution Data

US Market Release
CE Approval Date2004-04-07
Registered USA Implants
Estimated Active USA Implants
Normal Battery Depletions
US Market Release
CE Approval Date2004-04-07
Estimated WW Distribution3453
Normal Battery Depletions127
Information

Malfunctions (USA)

Therapy Function Not Compromised
Therapy Function Compromised
Information

Malfunctions (WW)

Therapy Function Not Compromised 40
Electrical Component 5
Possible Early Battery Depletion 34
Other 1
Therapy Function Compromised 1
Electrical Component 1
Information

Elective Replacement (ERI)

Battery voltage less the 2.62 V or charge time greater than 16 seconds.

Information

Charge Time

7285_7295_CHRG
Loading...

Data as of February 9, 2015

www.medtronic.com/productperformance 351052